Evaluation of Optimized Lead Candidates for Encephalitic Alphaviruses in Animal Models — Colleen B Jonsson (UNIVERSITY OF TENNESSE
Program Abstract- Project 2 Currently, there are no licensed human vaccines or antivirals for treating or preventing any encephalitic alphavirus infection. Because epidemics of alphaviruses are sporad
| Project title | Evaluation of Optimized Lead Candidates for Encephalitic Alphaviruses in Animal Models |
|---|---|
| Project number | 5U19AI142762-05 |
| PI name | Colleen B Jonsson |
| Institution | UNIVERSITY OF TENNESSEE HEALTH SCI CTR |
| Funding mechanism | U19 |
| Agency | NIAID |
| Award amount | $5.43M |
| Fiscal year | 2023 |
| Project start | 2019-03-06T00:00:00 |
| Project end | 2026-02-28T00:00:00 |
| Abstract | Program Abstract- Project 2 Currently, there are no licensed human vaccines or antivirals for treating or preventing any encephalitic alphavirus infection. Because epidemics of alphaviruses are sporad |
| Key terms | <Address><Aerosols><Alpha Virus><Alphavirus><Alphavirus Infections><Americas><Animal Model><Animal M |
$799/mo
Try GrantRadar →